151 related articles for article (PubMed ID: 31809823)
1. Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sézary syndrome.
Almukhtar R; Gill F; Soine R; McBurney E
J Am Acad Dermatol; 2020 Aug; 83(2):647-648. PubMed ID: 31809823
[No Abstract] [Full Text] [Related]
2. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
3. Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States.
Dores GM; Curtis RE; Anderson WF; Demierre MF
Arch Dermatol; 2008 Mar; 144(3):413-4. PubMed ID: 18347305
[No Abstract] [Full Text] [Related]
4. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.
Bi MY; Curry JL; Christiano AM; Hordinsky MK; Norris DA; Price VH; Duvic M
J Am Acad Dermatol; 2011 Jan; 64(1):53-63. PubMed ID: 21036417
[TBL] [Abstract][Full Text] [Related]
7. Survival prediction model for patients with mycosis fungoides/Sezary syndrome.
Zhu L; Han X; Liu Z; Leng S; Shan N; Lv X; Lu K; Hun S; Wu Y; Liu X
Future Oncol; 2020 Nov; 16(31):2487-2498. PubMed ID: 32746631
[No Abstract] [Full Text] [Related]
8. Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020.
Ottevanger R; de Bruin DT; Willemze R; Jansen PM; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Veraart JCJM; Vermeer MH; Quint KD
Br J Dermatol; 2021 Aug; 185(2):434-435. PubMed ID: 33690948
[No Abstract] [Full Text] [Related]
9. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
Lessin SR
Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
[No Abstract] [Full Text] [Related]
10. Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort study.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Duncan LM; Pongas G; Lazaryan A
J Am Acad Dermatol; 2020 Mar; 82(3):736-738. PubMed ID: 31238085
[No Abstract] [Full Text] [Related]
11. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
12. Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides.
Hurabielle C; Michel L; Ram-Wolff C; Battistella M; Jean-Louis F; Beylot-Barry M; d'Incan M; Bensussan A; Bagot M
J Invest Dermatol; 2016 Jan; 136(1):317-20. PubMed ID: 26763453
[No Abstract] [Full Text] [Related]
13. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
15. Survival of mycosis fungoides in patients in the Southeast of England.
Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides involving the cervical esophagus.
Redleaf MI; Moran WJ; Gruber B
Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):690-3. PubMed ID: 8499105
[TBL] [Abstract][Full Text] [Related]
17. Mycosis Fungoides and Sézary Syndrome: An Update.
Larocca C; Kupper T
Hematol Oncol Clin North Am; 2019 Feb; 33(1):103-120. PubMed ID: 30497668
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides: developments in incidence, treatment and survival.
Kaufman AE; Patel K; Goyal K; O'Leary D; Rubin N; Pearson D; Bohjanen K; Goyal A
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2288-2294. PubMed ID: 32141115
[TBL] [Abstract][Full Text] [Related]
19. Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study.
Blaizot R; Ouattara E; Fauconneau A; Beylot-Barry M; Pham-Ledard A
Br J Dermatol; 2018 Dec; 179(6):1322-1328. PubMed ID: 30098016
[TBL] [Abstract][Full Text] [Related]
20. A registry-based case-control study of mycosis fungoides.
Weinstock MA
Ann Epidemiol; 1991 Nov; 1(6):533-9. PubMed ID: 1669533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]